On 25-27 September 2019, Transcatheter cardiovascular therapeutics (TCT) -2019 Congress was held in San Francisco (California, USA). This is the largest event in endovascular surgery in the world.
Thousands of foreign experts present the latest researches in the field of interventional cardiology, present clinical trials and demonstrate innovations in the field of equipment, drugs and new methods of treatment at the Congress.
Surgeons from the Department of X-ray Surgical Methods for Diagnostic and Treatment No. 1 of Tyumen Cardiology Research Center take part in the TCT Congress every year. Bessonov I. S., MD, PhD, Head of the Laboratory of X-ray Surgical Methods for Diagnosis and Treatment of Cardiovascular Diseases No.1, Senior Scientific Researcher made an oral report. Ivan Bessonov presented a study devoted to the development of a scoring scale that allows to predict the risk of developing a life-threatening complication - the no-reflow phenomenon.
No-reflow is determined when patients with acute myocardial infarction, despite the restoration of coronary artery patency, do not have adequate blood supply to cardiac muscle. Developed scale allows scientists to predict the risk of this complication developing with high accuracy, which makes it possible to take the necessary measures to prevent it in a timely manner. This method was decided to patent and applied to Rospatent, about a year ago. Dr. Bessonov shared, that coincidentally, confirmation of the granted patent was received on the same day as the presentation of the report was made. Besides, I. P. Zyryanov, MD, PhD, Head of the Department of X-ray Surgical Methods for Diagnosis and Treatment of Cardiovascular Diseases No.1, Honored Doctor of the Russian Federation took part in the Congress.
Official website of the Congress https://www.crf.org/tct/